Morgan Stanley’s Calithera Biosciences, Inc CALA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-697
Closed -$2.27K 8020
2022
Q4
$2.27K Buy
697
+17
+3% +$55 ﹤0.01% 7339
2022
Q3
$2K Hold
680
﹤0.01% 7523
2022
Q2
$2K Sell
680
-385
-36% -$1.13K ﹤0.01% 7646
2022
Q1
$9K Sell
1,065
-9,687
-90% -$81.9K ﹤0.01% 7453
2021
Q4
$143K Buy
10,752
+8,803
+452% +$117K ﹤0.01% 6247
2021
Q3
$85K Sell
1,949
-47,326
-96% -$2.06M ﹤0.01% 6468
2021
Q2
$2.06M Buy
49,275
+49,258
+289,753% +$2.06M ﹤0.01% 4609
2021
Q1
$1K Sell
17
-2,610
-99% -$154K ﹤0.01% 7442
2020
Q4
$258K Buy
2,627
+2,180
+488% +$214K ﹤0.01% 5460
2020
Q3
$30K Sell
447
-788
-64% -$52.9K ﹤0.01% 5912
2020
Q2
$131K Buy
1,235
+861
+230% +$91.3K ﹤0.01% 5277
2020
Q1
$33K Sell
374
-2,948
-89% -$260K ﹤0.01% 5629
2019
Q4
$380K Buy
3,322
+2,409
+264% +$276K ﹤0.01% 5089
2019
Q3
$56K Buy
913
+793
+661% +$48.6K ﹤0.01% 5681
2019
Q2
$10K Sell
120
-328
-73% -$27.3K ﹤0.01% 6145
2019
Q1
$61K Sell
448
-2,047
-82% -$279K ﹤0.01% 5585
2018
Q4
$200K Sell
2,495
-1,322
-35% -$106K ﹤0.01% 5287
2018
Q3
$401K Buy
3,817
+427
+13% +$44.9K ﹤0.01% 5117
2018
Q2
$339K Sell
3,390
-52
-2% -$5.2K ﹤0.01% 5314
2018
Q1
$434K Sell
3,442
-135
-4% -$17K ﹤0.01% 5087
2017
Q4
$598K Buy
3,577
+564
+19% +$94.3K ﹤0.01% 4870
2017
Q3
$949K Sell
3,013
-2,911
-49% -$917K ﹤0.01% 4465
2017
Q2
$1.76M Buy
5,924
+1,016
+21% +$302K ﹤0.01% 3911
2017
Q1
$1.13M Buy
4,908
+4,483
+1,055% +$1.03M ﹤0.01% 4287
2016
Q4
$28K Buy
425
+202
+91% +$13.3K ﹤0.01% 5914
2016
Q3
$14K Sell
223
-58
-21% -$3.64K ﹤0.01% 6031
2016
Q2
$21K Sell
281
-88
-24% -$6.58K ﹤0.01% 5840
2016
Q1
$42K Sell
369
-111
-23% -$12.6K ﹤0.01% 5683
2015
Q4
$74K Buy
480
+354
+281% +$54.6K ﹤0.01% 5561
2015
Q3
$14K Buy
126
+75
+147% +$8.33K ﹤0.01% 6164
2015
Q2
$7K Buy
51
+36
+240% +$4.94K ﹤0.01% 6383
2015
Q1
$5K Sell
15
-21
-58% -$7K ﹤0.01% 6348
2014
Q4
$14K Buy
+36
New +$14K ﹤0.01% 6145